Assignee
YEDA RES & DEV
IL·995 granted patents·487 pending applications·24,781 citations·filing 1972–2025
Top patents by PatentIndex Score
1,482 records- 0198US9534052B2Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's diseaseYEDA RES & DEV·Filed 2016·Granted Jan 3, 2017·24 cites·35 claims
- 0298US9512227B2Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's diseaseYEDA RES & DEV·Filed 2016·Granted Dec 6, 2016·23 cites·32 claims
- 0398US9512225B2Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's diseaseYEDA RES & DEV·Filed 2016·Granted Dec 6, 2016·25 cites·30 claims
- 0498US9394365B1Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's diseaseYEDA RES & DEV·Filed 2015·Granted Jul 19, 2016·62 cites·30 claims
- 0598US7585837B2Reversible pegylated drugsYEDA RES & DEV·Filed 2005·Granted Sep 8, 2009·182 cites·105 claims
- 0698US7199098B2Copolymer-1 improvements in compositions of copolymersYEDA RES & DEV·Filed 2005·Granted Apr 3, 2007·84 cites·20 claims
- 0798US6939539B2Copolymer-1 improvements in compositions of copolymersYEDA RES & DEV·Filed 2003·Granted Sep 6, 2005·95 cites·33 claims
- 0898US6620847B2Copolymer-1 improvements in compositions of copolymersYEDA RES & DEV·Filed 2001·Granted Sep 16, 2003·119 cites·9 claims
- 0998US6362161B1Copolymer-1 improvements on compositions of copolymersYEDA RES & DEV·Filed 2000·Granted Mar 26, 2002·122 cites·1 claims
- 1098US6342476B1Copolymer-1 improvements in compositions of copolymersYEDA RES & DEV·Filed 2000·Granted Jan 29, 2002·130 cites·1 claims
- 1198US5966223APlanar holographic optical deviceYEDA RES & DEV·Filed 1997·Granted Oct 12, 1999·251 cites·8 claims
- 1298US5526338AMethod and apparatus for storage and retrieval with multilayer optical disksYEDA RES & DEV·Filed 1995·Granted Jun 11, 1996·395 cites·35 claims
- 1398US5114721APreparation of t-cell and t-cell membrane for use in prevention and treatment of autoimmune diseasesYEDA RES & DEV·Filed 1989·Granted May 19, 1992·176 cites·16 claims
- 1497US10144778B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2015·Granted Dec 4, 2018·24 cites·26 claims
- 1597US9856318B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2015·Granted Jan 2, 2018·22 cites·26 claims
- 1697US9155776B2Low frequency glatiramer acetate therapyYEDA RES & DEV·Filed 2015·Granted Oct 13, 2015·12 cites·30 claims
- 1797US7939072B2Anti-EGFR antibodies with an improved anti-tumor activity and compositions and articles of manufacture comprising sameYEDA RES & DEV·Filed 2009·Granted May 10, 2011·46 cites·2 claims
- 1897US7163802B2Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic useYEDA RES & DEV·Filed 2005·Granted Jan 16, 2007·64 cites·29 claims
- 1997US6169613B1Planar holographic optical device for beam expansion and displayYEDA RES & DEV·Filed 1997·Granted Jan 2, 2001·276 cites·22 claims
- 2097US6054430ACopolymer-1 improvements in compositions of copolymersYEDA RES & DEV·Filed 1998·Granted Apr 25, 2000·139 cites·6 claims
- 2197US5981589ACopolymer-1 improvements in compositions of copolymersYEDA RES & DEV·Filed 1998·Granted Nov 9, 1999·136 cites·1 claims
- 2297US5800808ACopolymer-1 improvements in compositions of copolymersYEDA RES & DEV·Filed 1995·Granted Sep 1, 1998·178 cites·1 claims
- 2397US5682255AHolographic optical devices for the transmission of optical signals of a plurality of channelsYEDA RES & DEV·Filed 1994·Granted Oct 28, 1997·259 cites·7 claims
- 2497US5578140ASolar energy plantYEDA RES & DEV·Filed 1995·Granted Nov 26, 1996·174 cites·52 claims
- 2597US5488664AMethod and apparatus for protecting visual information with printed cryptographic watermarksYEDA RES & DEV·Filed 1994·Granted Jan 30, 1996·230 cites·18 claims
- 2696US10214585B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2015·Granted Feb 26, 2019·14 cites·21 claims
- 2796US9982048B2Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's diseaseYEDA RES & DEV·Filed 2017·Granted May 29, 2018·12 cites·26 claims
- 2896US9982050B2Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's diseaseYEDA RES & DEV·Filed 2017·Granted May 29, 2018·12 cites·26 claims
- 2996US9982047B2Reducing systemic regulatory T cell levels or activity for treatment of Alzheimer's diseaseYEDA RES & DEV·Filed 2017·Granted May 29, 2018·12 cites·26 claims
- 3096US9982049B2Reducing systemic regulatory T cell levels or activity for treatment of alzheimer's diseaseYEDA RES & DEV·Filed 2017·Granted May 29, 2018·12 cites·26 claims
- 3196US9982051B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2017·Granted May 29, 2018·12 cites·20 claims
- 3296US9402874B2Low frequency glatiramer acetate therapyYEDA RES & DEV·Filed 2015·Granted Aug 2, 2016·10 cites·28 claims
- 3396US7625861B2Copolymer-1 improvements in compositions of copolymersYEDA RES & DEV·Filed 2007·Granted Dec 1, 2009·24 cites·11 claims
- 3496US7615359B2Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic useYEDA RES & DEV·Filed 2006·Granted Nov 10, 2009·32 cites·41 claims
- 3596US7560100B2Mixtures of polypeptides, compositions containing and processes for preparing same, for treating neurodegenerative diseasesYEDA RES & DEV·Filed 2005·Granted Jul 14, 2009·105 cites·43 claims
- 3696US7498142B2Methods of identifying combinations of antibodies with an improved anti-tumor activity and compositions and methods using the antibodiesYEDA RES & DEV·Filed 2006·Granted Mar 3, 2009·31 cites·11 claims
- 3796US6800287B2Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic useYEDA RES & DEV·Filed 2001·Granted Oct 5, 2004·79 cites·10 claims
- 3896US6048898ACopolymer-1 improvements in compositions of copolymersYEDA RES & DEV·Filed 1998·Granted Apr 11, 2000·134 cites·6 claims
- 3996US5906936AEndowing lymphocytes with antibody specificityYEDA RES & DEV·Filed 1993·Granted May 25, 1999·271 cites·33 claims
- 4096US5478925AMultimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing themYEDA RES & DEV·Filed 1992·Granted Dec 26, 1995·209 cites·7 claims
- 4196US4216188ACross-linked montmorillonite molecular sievesYEDA RES & DEV·Filed 1977·Granted Aug 5, 1980·95 cites·15 claims
- 4295US10618963B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2017·Granted Apr 14, 2020·10 cites·20 claims
- 4395US10519237B2Reducing systemic regulatory T cell levels or activity for treatment of disease and injury of the CNSYEDA RES & DEV·Filed 2016·Granted Dec 31, 2019·10 cites·30 claims
- 4495US7425332B2Treatment of autoimmune conditions with Copolymer 1 and related CopolymersYEDA RES & DEV·Filed 2006·Granted Sep 16, 2008·41 cites·20 claims
- 4595US7354575B2Method and pharmaceutical composition for treating inflammationYEDA RES & DEV·Filed 2005·Granted Apr 8, 2008·68 cites·7 claims
- 4695US7074580B2Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic useYEDA RES & DEV·Filed 2004·Granted Jul 11, 2006·78 cites·26 claims
- 4795US6621613B2Adaptive pulse compressorYEDA RES & DEV·Filed 2001·Granted Sep 16, 2003·52 cites·7 claims
- 4895US6544506B2Veto cells effective in preventing graft rejection and devoid of graft versus host potentialYEDA RES & DEV·Filed 2000·Granted Apr 8, 2003·54 cites·92 claims
- 4995US5958358AOriented polycrystalline thin films of transition metal chalcogenidesYEDA RES & DEV·Filed 1996·Granted Sep 28, 1999·311 cites·6 claims
- 5095US5912172AEndowing lymphocytes with antibody specificityYEDA RES & DEV·Filed 1995·Granted Jun 15, 1999·181 cites·41 claims
Showing the top 50 of 1,482 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →